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1. introduction 
The induction of cytoplasmic p-mutants by 
ethidium bromide(EB**) in the yeast Saccharomyces 
cerevisiae is a well known phenomenon [ 1 ] . These 
respiratory deficient mutants do not grow on non- 
fermentable substrates since their mitochondria are 
characterized by their abnormal content of respiratory 
enzymes and altered mitochondrial DNA [2] . 
The characterization and study of both nuclear 
and cytoplasmic yeast mutants resistant to EB is 
essential for the understanding of the mechanisms 
involved in the induction of respiratory deficient 
‘petite’ mutants in the so-called petite-positive 
yeasts [3], by this drug whenever non-fermentable 
substrates are used as carbon sources in the growing 
media [l] . 
One cytoplasmic and two different classes of 
nuclear mutants resistant to EB have been isolated 
and genetically characterized from the petite-negative 
yeast Kluyveromyces lactis [4,5] in our laboratory. 
The uptake and change of fluorescence (P*) of EB 
using whole cells was studied in wild type and these 
mutant strains with the purpose of elucidating the 
mechanism of actions of this drug. 
R was found that the degree of uptake of EB 
is greatly dependent on the nature of the substrate. 
Significant differences were observed between the 
wild type and the mutant in their capacity to bind 
this drug. 
* This work was supported in part by the Departamento de 
Bioquimica, Facultad de Medicina, UNAM 
** Abbreviations used: EB: ethidium bromide, af: change of 
fluorescence. 
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2. Materials and methods 
Kluyveromyces la&is (Saccharomyces lactis) wild 
type strain KZ12-A2: a, ade2 was a generous gift from 
Dr James R. Mattoon. The following EB resistant 
mutants that were previously selected and genetically 
characterized in our laboratory were used during the 
course of this work: KCl-8A: a,leu,EBR1; KD7-5B: 
a,adel,his,EBR2 and KDl-7A: a,leu,his, [EBR] 
(markers included in brackets have been shown to be 
cytoplasmically inherited). These strains were grown 
on solid YF’ADG medium containing: 1% Bacto-yeast 
extract, 2% Bacto-peptone, 4% (v/v) glycerol, 0.2% 
dextrose, 2% Bacto-agar and 80 mg/liter of adenine 
sulfate. 
Since cytoplasmic mutants resistant to EB are 
very unstable when high concentrations of dextrose 
are used [5] , this media contained only a small 
quantity of this substrate to help the growth get 
started. After 48 hours of growth, approximately 
5 g(wet weight) of cells were collected and starved in 
100 ml of sterilized 0.05 M potassium phosphate 
buffer pH 6.8 for 36 hr in a rotary shaker at 3O’C. 
After starvation the cells were centrifuged, washed 
and resuspended in distilled water in a ratio of 0.5 
g(wet weight) per ml of suspension. 
Two different types of experiments were carried 
out : 
2.1. Uptake of EB 
1 ml of the cell suspension (0.5 g wet weight) was 
added to the following medium: 4 ml of distilled 
water plus 0.6 ml of 0.2 M maleate-triethanolamine 
buffer pH 6; different substrates (glucose, fructose, 
lactate or ethanol) and different EB concentrations 
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were added to this medium as indicated under results. 
After the addition of the cells, the media was in- 
cubated at 30°C and stirred with a continuous air 
stream, aliquots were withdrawn at 0,3,6,10 and 15 
min intervals, rapidly placed in tubes of a Beckman 
Microfuge and centrifuged during 20 sec. The super- 
natant was separated with a Pasteur pipette and the 
concentration of EB was determined by measuring 
the fluorescence of adequate dilutions (1: 16) in a 
20 mM maleate-triethanolamine buffer pH 6. The 
wavelengths employed in the Farrand Mark I 
spectrofluorometer were 330 nm for excitation 
and 600 nm for emission. The results were compared 
each time with an EB standard curve going from 
4 to 40 MM at the same pH. All data obtained are 
reported in pmoles of EB uptake per gram of yeast 
cells (dry weight). 
2.2. Fluorescence changes (A f) of EB 
A spectrofluorometer 3 ml cuvette containing 
2.6 ml of distilled water, 0.3 ml of 0.2 M maleate- 
triethanolamine buffer pH 6; 0.16 ml of the cell 
suspension (0.5 g wet weight/ml) plus or minus 
0.05 ml of a 1 M glucose solution was used for these 
measurements. The A f was measured and recorded 
at 530 + 590 nm with different concentrations of 
EB and all the data reported are expressed as A f/min/ 
gram of yeast cells(dry weight). 
2.3. Chemicals 
Adenine sulfate, ethidium bromide and maleic 
anhydride were obtained from Sigma Chemical Co. 
Inorganic salts and triethanolamine from Merck and 
media for cultures from Difco. 
3. Results 
3.1. Uptake of EB of yeast whole cells 
A significant increase in the uptake of EB when 
either glucose or fructose were present in the incub- 
ation media was observed in all the strains with the 
exception of the cytoplasmic mutant(KDl-7A [EBR]), 
where the increase was about 1 pmolelg dry weight 
when these fermentable substrates were used. The 
uptake with the non-fermentable substrates was quite 
different since no significant increase in the uptake of 
the drug was found in the wild type(KZ12-A2) and 
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Fig.1. Effect of different kinds of substrates on ethidium 
bromide uptake by whole yeast cells. Cells were incubated 
in the presence of 100 WM EB and 80 mM substrate at 30°C, 
for 15 min. Samples were withdrawn at different intervals 
of time, quickly centrifuged in a Beckman microfuge for 
20 set, and the concentration of EB measured fluorometri- 
tally in the supernatant. Without substrate (a). Glucose 
(0); fructose (A); ethanol (A) and Lactate (m) strains: wild 
type (A); nuclear mutant EBR1 g); nuclear mutant EBR2 
(C) and cytoplasmic mutant [EB ] (D). 
cytoplasmic mutant with ethanol, while a small 
increase in the uptake of EB was detected in both 
nuclear mutants (KCI-8A EBR1 and KD7-SB EBR2), 
although not comparable to that obtained when the 
fermentable substrates were used. Lactate was found 
to inhibit almost all the EB uptake in all the strains. 
These results appear in fig.1. 
The uptake of EB at four different concentrations 
of this drug (60,100,200 and 300 MM) was measured 
in these strains (tig.2); significant differences were 
obtained between all the mutants and the wild type 
strain at the three lower concentrations of EB used 
(fIg.2B,C and D), while at the highest one (fig.2A), 
only the cytoplasmic mutant bound less EB than the 
wild type; at the same time, at all the concentrations 
the uptake of the cytoplasmic mutant was lower 
than that of all other strains. 
3.2.Changeofjluorescence(Af)ofEB 
An enhancement in the A f of EB was observed 
in the wild type strain as the concentration of this 
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Fig.2. Effect of ethidium bromide concentration on its 
uptake by whole yeast cells. Cells were incubated in the 
presence of 80 mM glucose and different EB concentrations 
at 3O’C for 15 min. Samples were withdrawn at different 
periods of time, centrifuged in a Beckman-Microfuge for 
20 set, and the concentration of EB in the supernatant 
measured fluorometrically. Concentrations of EB used: 
300 /JM (A); 200 nM (B); 100 nM (C) and 60 /.rM (D). 
Yeast strains: wild t e (0); nuclear mutant EBR1 (0); 
nuclear mutant EB l?? (A) and cytoplasmic mutant [EBR] (u). 
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Fig.3. Change of fluorescence of ethidium bromide 
induced by whole yeast cells in the presence (0) and 
absence (0) of 15 mM glucose. Yeast strains: wild type 
(A); nuclear mutant EBR1 (B); nuclear mutant EBR2 
(C) and cytoplasmic mutant [EBR] (D). 
drug was increased in the medium, this was less 
apparent when no glucose was added (fig.3A). 
Almost no change of the A f was detected with 
mutants KCl-8A (nuclear-l) and KDl-7A (cyto- 
plasmic) with or without glucose (tigs.3B and 3D). 
Only a slight increase in the A f was evident in mutant 
KD7-SB(nuclear-2) (iIg.3C). It can be noted that 
A f was higher in all strains when glucose was present 
in the incubation medium. 
4. Discussion 
Several mechanisms could be involved in conferring 
resistance to EB in these mutants. One possibility is 
that EB is not entering the mutant cell; our experi- 
mental data favors this point of view since the uptake 
of EB in all the mutants is much lower than that in 
the wild type, when the concentration of this drug 
does not exceed 100 MM in the incubation medium 
(figs.1 and 2). The concentrations of EB used for 
these assays are much higher than those employed 
for mutant selection and growth [4,5]. Fluorescence 
changes and uptake of EB in Saccharomyces cerevisiae 
have been found to be totally dependent on substrate 
availability and monovalent cation transport [6]. 
This would suggest that an alteration in the mono- 
valent cation transport system in one of these mutants 
could be responsible for the resistance to EB. A 
second possibility is that although EB is entering the 
cell, it is not reaching the specific site (probably the 
mitochondrial inner membrane) where it inhibits 
mitochondrial function. Change in the permeability 
of the mitochondrial membrane to this drug, or in 
the conformation of a mitochondrial membrane 
protein that binds EB, could be responsible for this 
effect as it is well known that a change in the hydro- 
phobicity or pH of the medium that surrounds EB 
induces a change in its fluorescence (A f) [7] ; if 
this specific site where EB inhibits mitochondrial 
function is a protein deeply imbedded in the inner 
mitochondrial membrane, the binding of EB by 
this protein would increase the A fin the wild type 
strain, but not in the mutants if the drug does not 
reach this site (flg.3). A change in the pH is less 
probable, since the external pH does not change in 
our conditions when EB and glucose are added to 
the medium (data not shown), glucose alone does 
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not change much the internal pH [8], but a 
change induced by the combination of EB and 
glucose or a compartmentalization f EB with a 
change of the pH cannot be overruled. 
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